AWM
TMDX icon

Abound Wealth Management’s Transmedics TMDX Stock Holding History

Abound Wealth Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67 Hold
1
– – ﹤0.01% 1335
2026
Q1 		$100 Sell
1
-1
-50% -$130 ﹤0.01% 1417
2025
Q4 		$244 Hold
2
– – ﹤0.01% 1114
2025
Q3 		$225 Hold
2
– – ﹤0.01% 1083
2025
Q2 		$269 Hold
2
– – ﹤0.01% 951
2025
Q1 		$135 Hold
2
– – ﹤0.01% 1149
2024
Q4 		$125 Buy
+2
New +$186 ﹤0.01% 1192

Other funds holding TMDX

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
STAS
Strong Tower Advisory Services Minneapolis, Minnesota $558M AUM 13.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
KGP
Keystone Global Partners Denver, Colorado $265M AUM 22.65% 1-Year Est. Return
CWMS
CFG Wealth Management Services Indianapolis, Indiana $107M AUM

Abound Wealth Management's TMDX Position: Q2 2026 in Review

Abound Wealth Management held its Transmedics (TMDX) position steady in Q2 2026 at 1 share worth $67. The position accounts for ﹤0.01% of the portfolio, ranked #1335.

Abound Wealth Management first reported a position in TMDX in Q4 2024 and has held it in 7 quarters since. The position peaked at $269 in Q2 2025. 34 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Abound Wealth Management held 1 share of Transmedics worth $67 as of Q2 2026.
  • Abound Wealth Management left its Transmedics share count unchanged in Q2 2026.
  • Transmedics made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #1335 holding.
  • Abound Wealth Management first reported a position in Transmedics in Q4 2024 and has held it in 7 quarters since.
  • Abound Wealth Management's Transmedics position peaked at $269 in Q2 2025.
  • 34 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.